Kindstar Globalgene Technology, Inc. (HKG:9960)
1.160
+0.010 (0.87%)
Apr 29, 2026, 3:45 PM HKT
HKG:9960 Revenue
In the year 2025, Kindstar Globalgene Technology had annual revenue of 933.57M CNY with 0.65% growth. Kindstar Globalgene Technology had revenue of 476.65M in the half year ending December 31, 2025, with 0.45% growth.
Revenue
933.57M CNY
Revenue Growth
+0.65%
P/S Ratio
1.10
Revenue / Employee
301.15K CNY
Employees
3,100
Market Cap
1.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mega Genomics | 275.03M |
| China Biotech Services Holdings | 73.50M |
| Biosino Bio-Technology and Science Incorporation | 205.08M |
| Adicon Holdings | 2.94B |
| Yunkang Group | 669.23M |
| Guanze Medical Information Industry (Holding) | 98.42M |
| King International Investment | 77.50M |
| China Health Group | 31.79M |